Intractable nausea and vomiting due to gastrointestinal mucosal metastases relieved by tetrahydrocannabinol (Dronabinol)

Journal of Pain and Symptom Management

Volumn 14, Issue 5, 1997, Pages 311-314

  Gonzalez Rosales, Francisco ^a   Walsh, Declan ^a  

^a TAUSSIG CANCER INSTITUTE   (United States)

Author keywords

Antiemetic; Dronabinol; Gastrointestinal mucosal metastases; Melanoma; Nausea; Tetrahydrocannabinol; Vomiting

Indexed keywords

ANTIEMETIC AGENT; DRONABINOL; PROCHLORPERAZINE; TETRAHYDROCANNABINOL;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ADVANCED CANCER; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG EFFICACY; HUMAN; MALE; MELANOMA; METASTASIS; NAUSEA; PALLIATIVE THERAPY; VOMITING;

ANTIEMETICS; GASTRIC MUCOSA; GASTROINTESTINAL NEOPLASMS; HUMANS; INTESTINAL MUCOSA; MALE; MIDDLE AGED; NAUSEA; TETRAHYDROCANNABINOL; VOMITING;

EID: 0030698703     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0885-3924(97)00229-7     Document Type: Article

References (16)

1. Drug Information for the Health Care Professional, USP DI, 1995:1184-1186.
2. McCabe M, Smith FP, MacDonald PV, et al. Efficacy of tetrahydrocannabinol in patients refractory to standar antiemetic therapy. Invest New Drugs 1988;6:243-246.
3. Schroeder DJ, Hart L, Lynch SS. Treatment for HIV wasting syndrome. Ann Pharmacotherapy 1994;8:295-297.
4. Beal JE, Olsen R, Laubenstein L, et al. Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS. J Pain Symptom Manage 1995;10;89-97.
5. Williams PI, Higgs A. Effect of nabilone on nausea and vomiting. Br J Anaesth 1995;74:111.
6. Meinick HM, Schonle PW, Conrad B. Effects of cannabinoids on spasticity and ataxia in multiple sclerosis. J Neurol 1989;236:120-122.
7. Martyn CN, Illis LS, Thom J. Nabilone in the treatment of multiple sclerosis. Lancet 1995;345: 579.
8. Nelson KA, Walsh D, Sheehan FA. The cancer anorexia cachexia syndrome. J Clin Oncol 1994;12: 213-225.
9. Nelson K, Walsh D, Deeter P, et al. A phase II study of delta-9-tetrahydrocannabinol for appetite stimulation in cancer-associated anorexia. J Palliat Care 1994;10:14-18.
10. Anonymous. Synthetic marijuana for nausea and vomiting due to cancer chemotherapy. Med Lett Drugs Ther 1985;27:97-98.
11. Donnelly S, Walsh D. The symptoms of advanced cancer. Semin Oncol 1995;22(suppl 3):67-72.
12. Gralla RJ. Adverse effects of treatments. In: DeVita VT, Hellman S, Rosemberg SA, eds. Cancer principles and practice of oncology. Lippincott, 1993:2338-2348.
13. Blach MB, Houghton AN, Peters LJ. Cutaneous melanoma. In: DeVita VT, Hellman S, Rosemberg SA, eds. Cancer principles and practice of oncology. Lippincott, 1993:1632-1633.
14. Wright DC, Delaney TF, Buckner JC. Treatment of metastatic cancer to the brain. In: DeVita VT, Hellman S, Rosemberg SA, eds. Cancer principles and practice of oncology. Lippincott, 1993:2170-2186.
15. Walsh TD. Antiemetic drug combination in advanced cancer. Lancet 1982;May:1018.
16. Hardman JG, Limbird LE, Molinoff PB. Goodman and Gilman's the pharmacological basis of therapeutics. McGraw-Hill, 1996:928-934.